Genocea Biosciences, Inc. Made Big Gain
Mon, Apr 11, 2022 at 05:30 PM
Genocea Biosciences, Inc. (GNCA:NASDAQ) rocketted at $0.6, a gain of 50%. On Fri, Apr 08, 2022, GNCA:NASDAQ touched a New 2-Week Low of $0.4. The stock got featured on our News Catalysts scanner on Fri, Apr 08, 2022 at 08:43 PM in the 'BIOTECH' category. From Fri, Mar 25, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days
About Genocea Biosciences, Inc. (GNCA:NASDAQ)
Genocea Biosciences Inc is a biopharmaceutical company that discovers and develops novel vaccines and immunotherapies to address diseases with unmet needs. The Company's products include GEN-003 and GEN-004.
Top 10 Gainers:
- Veru Inc. (VERU:NASDAQ), 182.3%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 71.57%
- Athersys, Inc. (ATHX:NASDAQ), 63%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 55.14%
- Genocea Biosciences, Inc. (GNCA:NASDAQ), 50%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 35.41%
- 21Vianet Group, Inc. (VNET:NASDAQ), 29.63%
- SailPoint Technologies Holdings, Inc. (SAIL:NYSE), 29.16%
- Reading International, Inc. (RDIB:NASDAQ), 25.54%
- 5E Advanced Materials Inc. (FEAM:NASDAQ), 24%